Skip to main content
TOPICS
Videos
Podcasts
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
FDASIA
FDA reneged on its promise to take a risk-based approach to CDS software
By
Bradley Merrill Thompson
|
02:23 pm |
April 11, 2018
At congressional hearing, FDA's Shuren talks digital health, patient engagement, real-world evidence
By
Jonah Comstock
|
03:51 pm |
March 31, 2017
Not much new in FDASIA report, Congress still champing at the bit
By
Jonah Comstock
|
12:19 pm |
April 04, 2014
How the FDA can improve regulation of mobile health, according to FDASIA workgroup
By
MHN Staff
|
08:07 am |
March 03, 2014
Analysis: 103 FDA regulated mobile medical apps
By
Brian Dolan
|
05:25 am |
November 26, 2013
In tense hearing, congressman declares "software is not a medical device"
By
Brian Dolan
|
06:18 am |
November 21, 2013
Part 2: Set FDA's mobile medical app guidance free
By
MHN Staff
|
01:15 pm |
September 04, 2013
Mobile health oversight: Stability will come with clarity, not rush
By
MHN Staff
|
12:59 pm |
September 04, 2013
Final days of waiting for FDA mobile medical app guidance?
By
Brian Dolan
|
06:40 am |
June 25, 2013
HHS workgroup could shape mHealth regulation
By
Jonah Comstock
|
08:48 am |
April 19, 2013